Harinder Gill: Arsenic Trioxide in newly-diagnosed Acute Promyelocytic Leukemia patients
Harinder Gill, Clinical Associate Professor in Haematology at HKU Medicine, shared a post on X:
“Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly-diagnosed patients: impact and outcome in Blood Advances of American Society of Hematology.”arsenic trioxide
Authors: Harinder Gill, Radha Raghupathy, Hsin-An Hou, Xavier Cheng-Hong Tsai, Adisak Tantiworawit, Melissa GM Ooi, Gin-Gin Gan, Chieh Lee Wong, Rita Lok Hay Yim, Lynn Chin, Paul Lee, Vivian Wing Kan Li, Lester Au, Qi Zhang, Garret M.K. Leung, Tony K.Y. Wu, Yu Yan Carmen Lee, Wee Joo Chng, Hwei-Fang Tien, Cyrus R. Kumana, Yok-Lam L Kwong
A great collaborative effort of the APL Asian Consortium.Oral arsenic trioxide (Arsenol or SDK001), an invention of HKUMed, is the first oral formulation of ATO globally with extensive data confirming efficacy and safety.
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023